The DOI matches its Crossref record; 45 of the 47 references it cites were found in a registry or an index.
Fructose ingestion acutely stimulates circulating FGF21 levels in humans
Open accessAbstract
OBJECTIVE: Fibroblast growth factor 21 (FGF21) is a hormone with pleiotropic metabolic activities which, in rodents, is robustly regulated by fasting and ketogenic diets. In contrast, similar dietary interventions have either no or minimal effects on circulating FGF21 in humans. Moreover, no intervention or dietary challenge has been shown to acutely stimulate circulating FGF21 in either humans or animals. Recent animal data suggest that the transcription factor Carbohydrate Responsive-Element Binding Protein (ChREBP) stimulates hepatic FGF21 expression and that fructose may activate hepatic ChREBP more robustly than glucose. Here, we examined whether fructose ingestion can acutely stimulate FGF21 in humans. METHODS: We measured serum FGF21, glucose, insulin, and triglyceride levels in ten lean, healthy adults and eleven adults with the metabolic syndrome following oral ingestion of 75 g of glucose, fructose, or a combination of the two sugars. RESULTS: FGF21 levels rose rapidly following fructose ingestion, achieved a mean 3.4-fold increase at two hours (P < 0.01), and returned to baseline levels within five hours. In contrast, FGF21 did not increase in the first two hours following ingestion of a glucose load, although more modest increases were observed after three to four hours. Both baseline and fructose-stimulated FGF21 levels were 2-3 fold elevated in subjects with metabolic syndrome. CONCLUSIONS: Fructose ingestion acutely and robustly increases serum FGF21 levels in humans in a pattern consistent with a hormonal response. While FGF21 appears to be critical for the adaptive response to fasting or starvation in rodents, these findings suggest that in humans, FGF21 may play an important role in fructose metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Starvation30,31, high sugar intake32,33 and dietary protein restriction26 all induce circulating FGF21 levels in humans.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [32]
In the citing paper
“FGF21 is induced by simple-sugar intake in both mice and humans22,32,33, and that sugar-induced production of FGF21 from the liver occurs in a ChREBP-dependent manner22,121.”
From Metabolic messengers: FGF21 (2021) · cites this paper as [32]
In the citing paper
“In addition, in humans, plasma FGF21 levels have been shown to be induced by increases in both glucose and insulin levels (31, 84, 110, 133), supporting a role during refeeding.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [31]
In the citing paper
“The ingestion of a single bolus of fructose or glucose induces plasma FGF21 levels in both lean healthy participants and patients with metabolic syndrome.”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [31]
In the citing paper
“While fructose markedly and acutely increased plasma FGF21 levels in humans, glucose caused a delayed and gradual increase in plasma FGF21 levels (31).”
From Fibroblast Growth Factor 21: A Versatile Regulator of Metabolic Homeostasis (2018) · cites this paper as [31]
In the citing paper
“Circulating FGF21 levels are robustly increased by diets that are high in carbohydrate but low in protein”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [138]
In the citing paper
“Both acute carbohydrate ingestion and long-term exposure to high-carbohydrate diets significantly increase liver FGF21 mRNA expression and circulating FGF21 levels”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [138]
In the citing paper
“liver FGF21 production seems to be robustly stimulated by an imbalance in macronutrients, particularly settings of high-carbohydrate but low-protein intake”
From FGF21 and the physiological regulation of macronutrient preference (2020) · cites this paper as [138]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
FGF-21 as a novel metabolic regulator
Kharitonenkov, A., Shiyanova, T. L., Koester, A., Ford, A. M., Micanovic, R., Galbreath, E. J., Sandusky, G. E., Hammond, L. J., Moyers, J. S., Owens, R. A., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23606 · Cited by 2,125
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Inagaki, T., Dutchak, P., Zhao, G., Ding, X., Gautron, L., Parameswara, V., Li, Y., Goetz, R., Mohammadi, M., Esser, V., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.003 · Cited by 1,504
Badman, M. K., Pissios, P., Kennedy, A. R., Koukos, G., Flier, J. S., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.05.002 · Cited by 1,495
Self-citationZhang, X., Yeung, D. C. Y., Karpisek, M., Stejskal, D., Zhou, Z.-G., Liu, F., Wong, R. L. C., Chow, W.-S., Tso, A. W. K., Lam, K. S. L., et al. (2008) · Diabetes · doi:10.2337/db07-1476 · Cited by 908
Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State
Fisher, F. M., Chui, P. C., Antonellis, P. J., Bina, H. A., Kharitonenkov, A., Flier, J. S., & Maratos-Flier, E. (2010) · Diabetes · doi:10.2337/db10-0193 · Cited by 830
Self-citationPotthoff, M. J., Inagaki, T., Satapati, S., Ding, X., He, T., Goetz, R., Mohammadi, M., Finck, B. N., Mangelsdorf, D. J., Kliewer, S. A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904187106 · Cited by 704
Flagged first, then by citations
2 of the 47 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 201–233 of 233
Wali, J. A., Ramos-Nieves, J. M., Binia, A., & van der Beek, E. M. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100713 · Cited by 1
Kataoka, H., Nirengi, S., Matsui, Y., & Taniguchi, H. (2024) · Journal of PHYSIOLOGICAL ANTHROPOLOGY · doi:10.1186/s40101-023-00353-0 · Cited by 1
The good, the bad, and the unknown: Fructose and FGF21
Hofmann, S. M., & Havel, P. J. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.11.002 · Cited by 1
Altered Adiponectin Response in Older Women Following Dextrose and High‐Fat Dietary Challenges
Herpich, C., Kochlik, B., Haß, U., Weber, D., Grune, T., & Norman, K. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202100487 · Cited by 1
The Sweet Path to Metabolic Demise: Fructose and Lipid
Herman, S. A., & Samuel, V. T. (2016)
Effets cardio-métaboliques des glucides
Amouyal, C., Mosbah, H., & Andréelli, F. (2018) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(18)30115-9
Lee, S. Y. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/136835
Rôle des hépatokines dans le dialogue inter-organes en physiologie et physiopathologie
Pacheco, A., & Postic, C. (2020) · Médecine des Maladies Métaboliques · doi:10.1016/j.mmm.2020.04.008
Yunker, A. G., Alves, J. M., LUO, S. H., ANGELO, B. C., DEFENDIS, A. W., Pickering, T. A., Jann, K., Monterosso, J. R., & Page, K. A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.29.446318
Development of a fibroblast growth factor 21 assay
Tamassia, G. V. (2017) · doi:10.32469/10355/62371
Gasperi, V., Vangapandu, C., Catani, M. V., & Savini, I. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0021027
FGF21 Counteracts Alcohol Intoxication by Activating Noradrenergic NeuronsPreprint
Choi, M., Schneeberger, M., Fan, W., Bugde, A., Gautron, L., Vale, K., Zhang, Y., Friedman, J. M., Mangelsdorf, D. J., & Kliewer, S. A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.09.502667
Cross-talk between hepatokines as Liver indused-exercise factors and organokinesPreprint
Rad, R. S. (2023) · Research Square · doi:10.21203/rs.3.rs-3734627/v1
Peterson, M. N., Adair, K. E., & Funderburk, L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.26.630421
Kardiyokinlerin Obezite ve Beslenme İle İlişkisi
Gerboğa, R., & Yılmaz, H. Ö. (2025) · Sağlık Bilimleri ve Klinik Araştırmaları Dergisi · doi:10.63695/jhscr.1601578
Rolph, T., & Birnbaum, M. J. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.07.002
Treviño‐Alvarez, A. M., de Baca, T. C., Stinson, E. J., Fry, H. T., Gluck, M. E., Chang, D. C., Piaggi, P., & Krakoff, J. A. (2025) · Nutrients · doi:10.3390/nu17193160
Bruse, J., Marbach, C., Polizzi, A., Landré, T., Salvi, J., Alquier‐Bacquie, V., Shiou-Ping, C., Huillet, M., Rives, C., Martin, C. M. P., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.22.683899
FGF21 attenuates traumatic brain injury-induced ferroptosis via activation of the Nrf2/GPX4 pathway
Xu, Y., Zhang, A., Zhang, G., & Qian, J. (2025) · Neurological Research · doi:10.1080/01616412.2025.2597834
Bogacheva, T. E., Геннадьевна, К. А., Гришина, Т. Р., Игоревич, Д. В., & Torshin, I. Y. (2026) · Pharmacoinformatics and pharmaconutritiology Current trends in data analysis · doi:10.63769/3034-7459-2025-1-1-29-40
Rôle des aminoacides ramifiés dans le déterminisme génétique de la résistance à l’insuline
Haydar, S. (2018) · theses.fr (ABES) · doi:10.70675/5c14c2c4z469bz40fazb55cz985ea78d6c2a
Homéostasie des céramides et hépatopathies métaboliques
Régnier, M. (2018) · theses.fr (ABES) · doi:10.70675/2fb92711z373cz4b27z8082z7aa3f8930e63
Influence du sexe dans la susceptibilité aux hépatopathies métaboliques
Smati, S. (2019) · theses.fr (ABES) · doi:10.70675/01997f55za990z41e6z96baz8221de2a6281
Inter-organ communication in physiology and pathophysiology : a role for the ChREBP-FGF21 axis?
Carbinatti, T. (2024) · theses.fr (ABES) · doi:10.70675/5d147ab4zad37z4f6bzac51z32a08efeaa51
Bruse, J., Marbach, C., Polizzi, A., Landré, T., Salvi, J., Alquier‐Bacquie, V., Chen, S.-P., Huillet, M., Rives, C., Céline, M., et al. (2026) · EMBO Reports · doi:10.1038/s44319-026-00790-9
Han, S., Shin, J., Kim, J. C., & Na, D. H. (2026) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-026-00815-4
Indian lychee honey mitigates hepatic lipotoxicity via FAM134B-mediated reticulo-mito-phagy in MASLD
Ghosh, C., Kundu, T., Pathak, T., Chatterjee, S., Kumar, P., Sircar, D., & Roy, P. (2026) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2026.103092 · Cited by 1
Suzuki, Y., Morita, A., Okaniwa, J., Tanaka, A., 長谷川, 祐., Sato, T., Higeta, D., & Iwase, A. (2026) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.70480
Alcohol, but not acetate, induces FGF21 in humans without association with subsequent food choice
Ramne, S., Dragsted, L. O., Dinjens, V., Magkos, F., Gillum, M. P., & Cuparencu, C. (2026) · The Journal of Nutritional Physiology · doi:10.1016/j.jnphys.2026.100048
Sumioki, H., Tomatsu, E., Seino, Y., Hidaka, S., Ueno, S., Kanie, S., Nishida, K., Haraguchi, T., Murao, N., Fujisawa, H., et al. (2026) · Physiological Reports · doi:10.14814/phy2.71117
Li, W., Zhu, K., Wu, L., Liao, Y., Liang, Y., Liu, M., & Chen, H. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119434
Metadata
- Authors
- Dushay, J. R., Toschi, E., Mitten, E. K., Fisher, F. M., Herman, M. A., & Maratos-Flier, E.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Broad Institute (US)
- Corresponding author
- Herman, Mark A.
- Venue
- Molecular Metabolism
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 4
- Issue
- 1
- Pages
- 51-57
- ISSN
- 2212-8778 (ISSN-L)
- PMC
- PMC4314524
- OpenAlex
- W2048578282
- Cited by
- 233
- References
- 47
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 19 · 2023: 16 · 2022: 22 · 2021: 22 · 2020: 14 · 2019: 28 · 2018: 20 · 2017: 29 · 2016: 22 · 2015: 11
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecular Metabolism (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DukeSpace (Duke University) (submittedVersion, cc-by-nc-nd)
- Funders
- JPB Foundation (8UL1TR000170-05)
- Harvard Catalyst/Harvard Clinical and Translational Science Center (1UL1 TR001102-01)
- EMF (R01DK028082)
- MAH (P30DK057521, R01DK100425)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Health Sciences › Medicine › Physiology (medical) › Dietary Effects on Health
- Keywords
- fructose, FGF21, glucose, carbohydrate-responsive element-binding protein, ChREBP, metabolic syndrome, fructose metabolism, insulin, triglycerides, fasting response
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
